Clinical Trials Logo

Intestinal Diseases clinical trials

View clinical trials related to Intestinal Diseases.

Filter by:

NCT ID: NCT05230875 Recruiting - Ulcerative Colitis Clinical Trials

Sexual Dysfunction Among Inflammatory Bowel Disease Adults-Clinical Trial

SexIA-CT
Start date: April 7, 2022
Phase:
Study type: Observational

Patients with Inflammatory Bowel Disease (IBD) have higher rates of sexual dysfunction than the general population. We offer an educational program on IBD including a specific discussion on intimacy and sexuality for IBD patients. Our objective is to investigate the benefit of this intervention on sexual function in patients with IBD.

NCT ID: NCT05224193 Recruiting - Clinical trials for Inflammatory Bowel Diseases

ACTIVE-IBD Study: Physical Activity and Sleep in Paediatric Inflammatory Bowel Disease

ACTIVE-IBD
Start date: November 1, 2021
Phase:
Study type: Observational

Assessment of physical activity on children with Inflammatory Bowel Disease using questionnaires and wrist watch based activity monitors. The participants will be recruited from paediatric IBD clinics and will undergo questionnaires to assess their activity level, disease activity and quality of life scores. The participants will then be invited to wear a wrist based accelerometer for a week. The participants will complete a physical activity diary, food diary and stool chart at the same time. Results will be analysed to see the level of physical activity and assess if the participants are meeting the recommended level of physical activity

NCT ID: NCT05224089 Recruiting - Bowel Disease Clinical Trials

Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy

TAPLIP
Start date: April 27, 2022
Phase: Phase 4
Study type: Interventional

This study will be a single center, prospective triple blinded randomized controlled study, comparing the use of liposomal bupivacaine (Exparel) to regular bupivacaine with adjuncts in bilateral mid-abdominal transverse abdominis plane (TAP) blocks for patients undergoing laparoscopic colectomy procedures.

NCT ID: NCT05223452 Not yet recruiting - Clinical trials for Inflammatory Bowel Diseases

Role of Ultrasound in Inflammatory Bowel Disease

Start date: May 1, 2022
Phase:
Study type: Observational

The aim of this article is to provide an extensive overview of the actual role of bowel ultrasound in the detection and follow-up of patients with chronic inflammatory bowel disease

NCT ID: NCT05214625 Completed - Clinical trials for Gastro-Intestinal Disorders

Questionnaire Study Concerning Artificial Intelligence

Start date: April 8, 2020
Phase:
Study type: Observational

This study aims to investigate the knowledge, experience, and opinion on AI among gastroenterology (GI) patients, gastroenterologists, and GI-fellows, particularly concerning implementation and application of AI (in assisting clinicians) in healthcare. The secondary aims are to investigate (dis)advantages of AI use in healthcare and the availability of technical facilities and infrastructures within endoscopy to implement and apply AI in Dutch hospitals.

NCT ID: NCT05211518 Recruiting - Clinical trials for Inflammatory Bowel Diseases

Prevention of Inflammatory Bowel Diseases in Persons at Risk The PIONIR (Preventing IBD Onset in Individuals at Risk) Trial

PIONIR
Start date: May 4, 2021
Phase: N/A
Study type: Interventional

The goal of this study is to explore in a cross over randomized controlled trial, the ability of the Tasty&Healthy dietary intervention (NCT04239248) to alter the parameters associated with future risk of developing Chron's disease (CD) using subjects identified in the Genetic Environmental Microbiome (GEM) Study as having a high-risk score. Specifically, the investigators aim to determine if the Tasty&Healthy dietary intervention can decrease the overall GEM Risk Score (GRS) and/or to alter the individual biological parameters that contribute to this score. The investigators hypothesize that the Tasty&Healthy dietary approach will alter the risk of CD as reflected by a decrease in the GRS.

NCT ID: NCT05209568 Recruiting - Celiac Disease Clinical Trials

Immune Responses to Gluten

Start date: January 15, 2023
Phase: N/A
Study type: Interventional

This is a study of immune responses after eating gluten powder in people with celiac disease and healthy controls.

NCT ID: NCT05206734 Completed - Schizophrenia Clinical Trials

Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on Health

Start date: January 5, 2022
Phase:
Study type: Observational

This study is a large population-based analysis in the United Kingdom (UK) using routine primary care data to investigate the risk of mental health conditions in children, adolescents and young adults with Inflammatory Bowel Disease, compared to those without Inflammatory Bowel Disease. The study will also compare the impacts on quality-of-life outcomes and use of healthcare services between people with Inflammatory Bowel Disease with and without mental health conditions.

NCT ID: NCT05202418 Completed - Clinical trials for Inflammatory Bowel Diseases

Stress in Inflammatory Bowel Disease

Start date: February 27, 2022
Phase: N/A
Study type: Interventional

This is a prospective, assessment-based study to examine the relationship between psychophysiological functioning and psychological symptoms in youth newly diagnosed with inflammatory bowel disease (IBD) compared to healthy controls.

NCT ID: NCT05200325 Completed - Barrett Esophagus Clinical Trials

Clinical Utility Evidence for TissueCypher®

Start date: June 6, 2021
Phase: N/A
Study type: Interventional

Cernostics has developed a new diagnostic test, and this study will measure how gastroenterologists and foregut surgeons make diagnostic and treatment decisions when presented with different information in the context of simulated clinical cases. The results of this study could contribute to improved quality of care for patients by encouraging better care practices and adherence to evidence-based guidance. The data from this study will be provided to all participating physicians and submitted to a national journal for publication. The study plans to enroll up to 249 physicians.